The average level of blood thinning, resulting from an individual weight determined dose of Clexane, when given to women after caesarian section to prevent blood clots.

Phase 4

Recruiting

• Conditions: thromboprophylaxis for caesarian section; Blood - Clotting disorders; Reproductive Health and Childbirth - Childbirth and postnatal care

• Registration Number: ACTRN12611001003965
• Lead Sponsor: Mercy Hospital For Women

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-09-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 160

Inclusion Criteria

post caesarian section.
patient classified as high or intermediate risk of VTE based upon BCOG guidelines 2009

Exclusion Criteria

refusal to enter trial
no booking maternal weight obtainable

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
plasma AntiXa levels[baseline, 4 hours post first & third doses]

Secondary Outcome Measures

Name	Time	Method
il[Nil]